CD40 inhib 
Welcome,         Profile    Billing    Logout  
 11 Companies   12 Products   12 Products   40 Diseases   6 Trials   375 News 

Download options
                                                                                                      
 Phase 
N/A
1
2
3
4
 Trials
 02468101214161820
            
            
             
iscalimab (CFZ533) / Novartis           
          
            
             
dacetuzumab (SGN-40) / Pfizer           
          
            
             
bleselumab (ASKP1240) / Astellas, Kyowa Kirin           
          
            
             
Galepa (daleuton topical) / DS Biopharma           
          
            
             
daleuton oral (DS107 oral) / DS Biopharma           
          
            
             
abiprubart (KPL-404) / Kiniksa           
          
            
             
lucatumumab (CHIR 12.12) / Novartis, Xoma           
          
            
             
CD40.HIVRI.Env / ANRS           
          
            
             
BIIB063 / Biogen           
          
            
             
BMS-986090 / BMS           
          
            
             
NJA-730 / NapaJen Pharma